Vaccine

Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine

Merck & Co.

M&A

TriRx Pharmaceutical Services Acquires MSD Animal Health Manufacturing Site located in Segre-en Anjou Bleu, France Including Long-term Supply Agreement

TriRx Pharmaceutical Services

Collaboration

Merck and IRBM Announce Pioneering Collaboration to Advance Peptide Therapeutics

IRBM

COVID-19 Vaccine

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

Merck & Co.

M&A

Merck to Acquire Themis

Merck & Co.

Emergency Response

Merck to Donate 300,000 Masks to New Jersey for COVID-19 Emergency Response

Merck & Co.

Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic

Eli Lilly and Company

3D Printing

Merck KGaA, Darmstadt, Germany and AMCM / EOS Cooperate in 3D Printing of Tablets

MilliporeSigma

M&A

Merck to Acquire ArQule, Advancing Leadership in Oncology

Merck & Co.

Vaccine Approval

Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

Merck & Co.

Vaccine

CDC Advisory Recommends Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26

Merck & Co.

Track and Trace

IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity

Merck & Co.

M&A

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck & Co.

FDA Approval

Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)

Eisai